» » Aurinia lupus candidate hits PhII target, but deaths send stock down - FierceBiotech

Aurinia lupus candidate hits PhII target, but deaths send stock down - FierceBiotech


FierceBiotech
Aurinia lupus candidate hits PhII target, but deaths send stock down
FierceBiotech
Aurinia Pharmaceuticals has published positive new data for its experimental drug voclosporin for active lupus nephritis--but 12 deaths in the study's treatment arm has sent alarm bells ringing. Canadian biotech Aurinia Pharmaceuticals ($AUPH) posted ...
Aurinia Pharmaceuticals (AUPH) Stock Tumbles on Lupus Drug Trial DeathsTheStreet.com
Aurinia Pharmaceuticals Announces Voclosporin Meets Primary Endpoint in Phase IIB AURA-LV Study in Lupus ...Business Wire (press release)
Lupus Foundation of America Statement on Successful Results of Phase IIB Clinical Trial of VoclosporinMarketwired (press release)
StreetInsider.com -24/7 Wall St. -Seeking Alpha -Schaeffers Research (blog)
all 14 news articles »

Aurinia lupus candidate hits PhII target, but deaths send stock down - FierceBiotech
Read More

0 Response to "Aurinia lupus candidate hits PhII target, but deaths send stock down - FierceBiotech"

Post a Comment

Subscribe to: Post Comments (Atom)